World News

Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in...

Ogkologos - 11 Αυγούστου, 2026

Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary...

Ogkologos - 10 Αυγούστου, 2026

EMA Recommends Extension of Indications for Ponatinib Associated with a New...

Ogkologos - 7 Αυγούστου, 2026

Could Functional Precision Medicine Be the New Precision Oncology?

Ogkologos - 6 Αυγούστου, 2026

Adding Pirtobrutinib to Venetoclax-Rituximab Shows Significant Improvement in PFS Among Patients...

Ogkologos - 6 Αυγούστου, 2026

FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab...

Ogkologos - 5 Αυγούστου, 2026

Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause...

Ogkologos - 4 Αυγούστου, 2026

Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into...

Ogkologos - 3 Αυγούστου, 2026

EMA Recommends Extension of Therapeutic Indications for Serplulimab

Ogkologos - 31 Ιουλίου, 2026

Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II...

Ogkologos - 30 Ιουλίου, 2026

1...91011...432 Σελίδα 10 από 432

MOST POPULAR

Indigenous Women with Early Stage Breast Cancer Get Mastectomies at Higher...

10 Νοεμβρίου, 2021

Immune Checkpoint Inhibitor Induced Thyroiditis Associated with a Large Reduction in...

20 Μαΐου, 2021

Neoadjuvant GOLP Prolongs EFS Among Patients with Resectable High-Risk Intrahepatic Cholangiocarcinoma

16 Μαρτίου, 2026

EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma

11 Δεκεμβρίου, 2024

Φόρτωση περισσοτέρων

Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in...

Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary...

EMA Recommends Extension of Indications for Ponatinib Associated with a New...

Could Functional Precision Medicine Be the New Precision Oncology?

Adding Pirtobrutinib to Venetoclax-Rituximab Shows Significant Improvement in PFS Among Patients...

FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab...

Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause...

Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into...

EMA Recommends Extension of Therapeutic Indications for Serplulimab

Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II...

MOST POPULAR

Indigenous Women with Early Stage Breast Cancer Get Mastectomies at Higher...

Immune Checkpoint Inhibitor Induced Thyroiditis Associated with a Large Reduction in...

Neoadjuvant GOLP Prolongs EFS Among Patients with Resectable High-Risk Intrahepatic Cholangiocarcinoma

EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma

HOT NEWS

Five Questions With…Stephen.

Patient Guide on Immunotherapy Side Effects and Their Management Now Available...

How My Metastatic Cancer Diagnosis Led Me to a Full-Time Career...

11-Year-Old Cancer Survivor With One Leg Dances With Professional Tapper Lord...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ